KBI Biopharma Inc. sell "PUREplatform™"

PUREplatform™ is KBI Biopharma's proprietary microbial expression system for clean, scalable and cost-effective production of therapeutic proteins in E. coli. Centered on the high-yield PUREcoli™ strain, it integrates expression plasmids (PUREplasmids™), media (PUREmedia™) and fermentation processes into a modular service tailored to each molecule. Key capabilities include titers up to 50 g/L, fully integrated screening packages of 8, 24, 48 or 96 conditions, and optimization for secreted proteins, inclusion bodies and soluble intracellular targets — suited to antibody fragments (Fabs), enzymes and novel biologics.